July 28, 2021 09:30 AM EDTUpdated 09:43 AM

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU

Josh Sullivan

Zachary Brennan

Senior Editor

Thirteen cases of thrombosis with thrombocytopenia syndrome in recipients of the AstraZeneca Covid-19 vaccine have led to a number of countries pausing its authorization. On …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: As­traZeneca pub­lish­es da­ta on blood clots as­so­ci­at­ed with vac­cine; Glax­o­SmithK­line and Vir ink mAb sup­ply deal with EU

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU